Notice of Extraordinary General Meeting in Xspray Pharma AB (publ) PR Newswire STOCKHOLM, Jan. 31, 2018 STOCKHOLM, Jan. 31, 2018 /PRNewswire/ -- The shareholders of Xspray Pharma AB (publ) are...
Notice of Extraordinary General Meeting in Xspray Pharma AB (publ) PR Newswire STOCKHOLM, Jan. 31, 2018 STOCKHOLM, Jan. 31, 2018 /PRNewswire/ -- The shareholders of Xspray Pharma AB (publ) are...
XSpray Pharma Proposes a Directed Issue of 1,350,000 Shares Corresponding to Approximately SEK 88 Million to Expand the Product Portfolio PR Newswire STOCKHOLM, Sweden, Jan. 30, 2018 STOCKHOLM...
XSpray Pharma Proposes a Directed Issue of 1,350,000 Shares Corresponding to Approximately SEK 88 Million to Expand the Product Portfolio PR Newswire STOCKHOLM, Sweden, Jan. 30, 2018 STOCKHOLM...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 78.8 | 78.8 | 78.8 | 0 | 0 | DE |
4 | 0 | 0 | 78.8 | 78.8 | 78.8 | 0 | 0 | DE |
12 | 0 | 0 | 78.8 | 78.8 | 78.8 | 47 | 78.8 | DE |
26 | 0 | 0 | 78.8 | 78.8 | 78.8 | 92 | 78.8 | DE |
52 | 0 | 0 | 78.8 | 78.8 | 78.8 | 69 | 78.8 | DE |
156 | 0 | 0 | 78.8 | 78.8 | 78.8 | 43 | 78.8 | DE |
260 | 0 | 0 | 78.8 | 78.8 | 78.8 | 32 | 78.8 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約